Published in BMC Complement Altern Med on April 10, 2012
Mixed Methods in CAM Research: A Systematic Review of Studies Published in 2012. Evid Based Complement Alternat Med (2013) 1.08
Primary care physicians, acupuncture and chiropractic clinicians, and chronic pain patients: a qualitative analysis of communication and care coordination patterns. BMC Complement Altern Med (2016) 0.81
Process of care in outpatient Integrative healthcare facilities: a systematic review of clinical trials. BMC Health Serv Res (2015) 0.75
Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med (2007) 3.80
Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med (2004) 2.92
Randomized trial of 5 dollars versus 10 dollars monetary incentives, envelope size, and candy to increase physician response rates to mailed questionnaires. Med Care (2002) 2.30
Integrative medicine: bringing medicine back to its roots. Arch Intern Med (2002) 2.04
Patient-centered communication: do patients really prefer it? J Gen Intern Med (2004) 1.63
Alternative medicine or "alternative" patients: a qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine. Med Decis Making (2004) 1.59
Complementary medicine in general practice - a national survey of GP attitudes and knowledge. Aust Fam Physician (2010) 1.56
Physician response rates to a mail survey by specialty and timing of incentive. Am J Prev Med (2004) 1.55
Are people who use "natural drugs" aware of their potentially harmful side effects and reporting to family physician? Patient Educ Couns (2004) 1.53
On the definition of complementary, alternative, and integrative medicine: societal mega-stereotypes vs. the patients' perspectives. Altern Ther Health Med (2003) 1.53
From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med (2004) 1.52
A gap between acceptance and knowledge of herbal remedies by physicians: the need for educational intervention. BMC Complement Altern Med (2005) 1.48
Pharmaceutical care for patients with skin diseases: a campaign year at Swedish pharmacies. J Clin Pharm Ther (1995) 1.46
How and where clinicians exercise power: interprofessional relations in health care. Soc Sci Med (2010) 1.43
Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. BMC Complement Altern Med (2010) 1.27
A qualitative study of patient's views on the consultation at the Glasgow Homoeopathic Hospital, an NHS integrative complementary and orthodox medical care unit. Patient Educ Couns (2004) 1.25
Academic doctors' views of complementary and alternative medicine (CAM) and its role within the NHS: an exploratory qualitative study. BMC Complement Altern Med (2007) 1.18
What complementary and alternative medicine practitioners say about health and health care. Ann Fam Med (2004) 1.17
Patients' perceptions of primary care physicians' participatory decision-making style and communication about complementary and alternative medicine for arthritis. J Altern Complement Med (2005) 1.17
Physician participation in research surveys. A randomized study of inducements to return mailed research questionnaires. Eval Health Prof (1999) 1.12
The use of monetary incentives in a community survey: impact on response rates, data quality, and cost. Health Serv Res (2001) 1.10
Exploring medication use to seek concordance with 'non-adherent' patients: a qualitative study. Br J Gen Pract (2002) 1.09
Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Carolina Complementary Medicine Program Baseline Research Team. South Med J (2000) 1.06
The future of complementary and alternative medicine--models of integration. J Altern Complement Med (2004) 1.05
A survey of primary care physicians' perceptions of their patients' use of complementary medicine. Complement Ther Med (2003) 1.03
Barriers to patient referral for Complementary and Alternative Medicines and its implications on interventions. Complement Ther Med (2010) 1.02
Perceptions around concordance--focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expect (2004) 0.95
Roles and responsibilities of pharmacists with respect to natural health products: key informant interviews. Res Social Adm Pharm (2009) 0.95
What rheumatologists in the United States think of complementary and alternative medicine: results of a national survey. BMC Complement Altern Med (2010) 0.93
Improving patient-doctor concordance: an intervention study in general practice. Fam Pract (1996) 0.93
Qualitative research and the profound grasp of the obvious. Health Serv Res (1999) 0.92
Medical doctors and complementary and alternative medicine: the context of holistic practice. Health (London) (2006) 0.91
Problem-solving and decision-making preferences: no difference between complementary and alternative medicine users and non-users. Complement Ther Med (2005) 0.87
Patient choice and evidence based decisions: The case of complementary therapies. Health Expect (2009) 0.86
Using a problem detection study (PDS) to identify and compare health care provider and consumer views of antihypertensive therapy. J Hum Hypertens (2003) 0.85
Australian community pharmacists' practice in complementary medicines: a structural equation modeling approach. Patient Educ Couns (2011) 0.84
The asthma year in Swedish pharmacies: a nationwide information and pharmaceutical care program for patients with asthma. Ann Pharmacother (1996) 0.83
Complementary and alternative medicine: perception and use by physiotherapists in the management of low back pain. Complement Ther Med (2011) 0.81
Complementary medicine prescription patterns in Germany. Ann Pharmacother (2004) 0.81
Musculoskeletal pain and treatment choice: an exploration of illness perceptions and choices of conventional or complementary therapies. Disabil Rehabil (2010) 0.78
Familiarity breeds discontent: senior hospital doctors' attitudes towards complementary/alternative medicine. Complement Ther Med (2007) 0.78
The use of CAM in a New Zealand-based general practice: a multiple case-study. Complement Ther Med (2007) 0.77
Towards concordance in healthcare: perspectives of general practitioners, complementary and alternative medicine practitioners and pharmacists in Australia. J Clin Pharm Ther (2010) 0.76
Examining sites of interface between CAM and conventional health care: extending the sociological gaze. Complement Ther Med (2004) 0.76
Perceived problems of pharmacotherapy: a problem detection study among physicians and nurses at a Swedish university hospital. Pharm World Sci (1999) 0.76
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet (2004) 2.58
Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis. Clin Biochem (2007) 2.06
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet (2007) 1.79
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin Pharmacokinet (2010) 1.46
Systematic review of interventions to improve prescribing. Ann Pharmacother (2009) 1.35
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clin J Am Soc Nephrol (2010) 1.33
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Clin Pharmacol Ther (2002) 1.21
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Clin Pharmacokinet (2010) 1.20
Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Ther Drug Monit (2003) 1.19
Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration. Br J Clin Pharmacol (2004) 1.16
Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Med Care (2006) 1.12
Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transpl (2003) 1.11
Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. J Rheumatol (2002) 1.08
What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia? Pharmacoepidemiol Drug Saf (2007) 1.01
Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis. Br J Clin Pharmacol (2005) 0.99
A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments. Int J Qual Health Care (2010) 0.99
How is medication prescribing ceased? A systematic review. Med Care (2011) 0.96
A Bayesian approach for population pharmacokinetic modelling of sirolimus. Br J Clin Pharmacol (2006) 0.96
Perceptions around concordance--focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expect (2004) 0.95
Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients. Ther Drug Monit (2002) 0.93
Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets. Antimicrob Agents Chemother (2011) 0.92
Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection. Br J Clin Pharmacol (2008) 0.91
Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol (2014) 0.91
Quality Use of Medicines--medication safety issues in naming; look-alike, sound-alike medicine names. Int J Pharm Pract (2012) 0.91
Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. Eur J Clin Pharmacol (2005) 0.91
A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiol Drug Saf (2008) 0.90
Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs Aging (2005) 0.88
Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Ther Drug Monit (2004) 0.88
Perceived barriers to paracetamol (acetaminophen) prescribing, especially following rofecoxib withdrawal from the market. Clin Rheumatol (2009) 0.87
Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clin Ther (2009) 0.85
Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. Br J Clin Pharmacol (2005) 0.85
Management of acute coronary syndromes at hospital discharge: do targeted educational interventions improve practice quality? J Healthc Qual (2011) 0.85
Drug utilization review across jurisdictions--a reality or still a distant dream? Eur J Clin Pharmacol (2006) 0.84
Privacy and confidentiality: perspectives of mental health consumers and carers in pharmacy settings. Int J Pharm Pract (2014) 0.84
Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia. Clin Ther (2005) 0.83
Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm (2012) 0.83
Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Ther Drug Monit (2003) 0.83
Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy. Pharmacoepidemiol Drug Saf (2014) 0.83
Cyclosporin monitoring in Australasia: 2002 update of consensus guidelines. Ther Drug Monit (2002) 0.82
Trust and safe spaces: mental health consumers' and carers' relationships with community pharmacy staff. Patient (2013) 0.82
Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet? Clin Pharmacokinet (2011) 0.82
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clin Pharmacokinet (2013) 0.81
How is leflunomide prescribed and used in Australia? Analysis of prescribing and adverse effect reporting. Pharmacoepidemiol Drug Saf (2006) 0.81
Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Ther Drug Monit (2004) 0.81
Review of community pharmacy staff educational needs for supporting mental health consumers and carers. Community Ment Health J (2013) 0.80
Improving the use of benzodiazepines--is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Serv Res (2010) 0.80
Safety evaluation of leflunomide in rheumatoid arthritis. Expert Opin Drug Saf (2013) 0.79
Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.79
Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia. BMC Health Serv Res (2008) 0.79
Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period 1992-2004. Pharmacoepidemiol Drug Saf (2006) 0.78
Medication management reviews for people from the former Yugoslavia now resident in Australia. Pharm World Sci (2004) 0.78
Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors. Eur J Clin Pharmacol (2005) 0.78
Influences on doctors' prescribing: is geographical remoteness a factor? Aust J Rural Health (2003) 0.78
A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transpl (2004) 0.77
The Queensland experience of participation in a national drug use evaluation project, Community-Acquired Pneumonia Towards Improving Outcomes Nationally (CAPTION). BMC Pulm Med (2009) 0.77
Consumer involvement in Quality Use of Medicines (QUM) projects - lessons from Australia. BMC Health Serv Res (2005) 0.77
The Australian rise of esomeprazole-was expenditure on samples a contributor? Pharmacoepidemiol Drug Saf (2009) 0.77
A comparison of benzodiazepine and related drug use in Nova Scotia and Australia. Can J Psychiatry (2008) 0.76
Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.76
Innovation in hospital quality improvement activities--acute postoperative pain management (APOP) self-help toolkit audits as an example. J Healthc Qual (2012) 0.76
Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. Eur J Clin Pharmacol (2002) 0.76
Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia. Aust J Rural Health (2005) 0.75
A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme. Pharmacoepidemiol Drug Saf (2009) 0.75
Is statin use associated with new joint-related symptoms, physical function, and quality of life? Results from two population-based cohorts of women. Arthritis Care Res (Hoboken) (2015) 0.75
Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia. Eur J Clin Pharmacol (2003) 0.75
An intervention to improve benzodiazepine use--a new approach. Fam Pract (2010) 0.75